Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Allergy and Immunology · Acquired Angioedema with C1 Inhibitor Deficiency

The Biology of AAE and Your Lab Results

At a Glance

Acquired angioedema with C1 inhibitor deficiency causes swelling when excess bradykinin makes blood vessels leak. Low C4 and low C1-INH function support the diagnosis, while low C1q can point to an acquired immune or blood disorder rather than hereditary angioedema.

Understanding why your body is swelling requires looking deep into your blood chemistry. While an allergy is a “histamine” problem, Acquired Angioedema (AAE-C1-INH) is a “bradykinin” problem [1].

To manage this condition, it helps to understand the molecular chain reaction that causes your blood vessels to leak and how your laboratory results provide the “map” your doctors use to treat you. Patients should not diagnose themselves from one abnormal result; repeat testing is often needed.

The Molecular Chain Reaction

Your blood contains a complex network of proteins called the contact system (also known as the kallikrein-kinin system) [2]. Under normal conditions, this system helps regulate blood pressure and inflammation.

Think of this system like a high-pressure garden hose. To keep the water from spraying everywhere, your body uses a “brake” or “regulator” protein called C1 Inhibitor (C1-INH) [3].

When you have a deficiency of C1-INH:

  1. The Brake Fails: Without enough C1-INH, an enzyme called kallikrein becomes overactive [4].
  2. The Leak Starts: Kallikrein clips a larger protein into a smaller peptide called bradykinin [5].
  3. The Swelling Occurs: Excessive bradykinin binds to the lining of your blood vessels, signaling them to open up [1]. Fluid from your blood then leaks into the surrounding tissue, causing the deep, heavy swelling you experience [6].

How Your C1 Inhibitor Disappears

In the hereditary version of this disease, people are born with a genetic mutation that prevents them from making enough C1-INH. In Acquired Angioedema, your body knows how to make the protein, but something is destroying it or using it up faster than you can produce it [5][7].

There are two primary ways this happens:

1. Consumption (Type I Mechanism)

In some patients, another underlying condition—often a B-cell lymphoproliferative disorder (a type of blood cell growth) or MGUS (abnormal proteins in the blood)—constantly activates the immune system [8][9]. This constant activation “consumes” or uses up the C1-INH supply, leaving you unprotected [5].

2. Autoantibodies (Type II Mechanism)

In other cases, your immune system mistakenly identifies your C1-INH as a threat. It produces autoantibodies—immune “hijackers” that stick to the C1-INH protein and neutralize it [10][11]. Even if your body is making plenty of C1-INH, these antibodies ensure it can’t do its job [7].

Reading Your Lab Results

When you look at your blood work, your doctor focuses on a specific group of tests called complement levels. Here is what those numbers typically mean in AAE-C1-INH:

Test Name Typical Result in AAE What It Tells Your Doctor
C4 (Complement 4) Low This is the “screening” test. Because the system is constantly “on,” C4 is frequently used up and will be low [12].
C1-INH Antigen Low or Normal This measures the amount of the protein. It is often low, but it can be normal if you are producing enough protein but it’s being neutralized by antibodies [13].
C1-INH Function Low This is the most critical test. It measures how well your “brakes” are actually working. Even if the amount (antigen) is normal, the function will be low in AAE [13][14].
C1q Low This is a very helpful marker for AAE. C1q is a protein used early in the complement chain. In the hereditary form (HAE), C1q is usually normal. In AAE, C1q is frequently low, though it can sometimes be normal [14][15].
Anti-C1-INH Antibodies Positive (often) If these are present, it supports that your body is actively attacking its own C1-INH. However, a negative test does not exclude AAE [10].

The Importance of the C1q Result

If you were diagnosed later in life, the C1q test is the most important tool for distinguishing your condition from the hereditary form (HAE) [14].

In HAE, the “factory” (your genes) is broken, but the rest of the immune system is usually quiet, so C1q levels stay normal [14]. In AAE, the immune system is “hyper-active”—often due to an underlying condition—which causes the C1q protein to be used up alongside the C1-INH [5][7].

Finding a low C1q level is often what prompts your doctor to look deeper for an underlying condition, such as a B-cell or plasma-cell disorder, which might be the root cause of your angioedema [9][8]. Monitoring these lab values over time can help your doctor see how well your treatment is working to bring the system back into balance [7].

Common questions in this guide

How is acquired angioedema with C1 inhibitor deficiency different from an allergy?
Acquired angioedema with C1 inhibitor deficiency is usually driven by excess bradykinin, a chemical that makes blood vessels leak, rather than by histamine from an allergy. This difference is why clinicians use complement and C1 inhibitor tests to evaluate the cause of swelling.
What do low C4 and low C1q mean in acquired angioedema?
Low C4 often indicates that the complement system is being activated and used up. Low C1q can support an acquired cause rather than hereditary angioedema, although C1q may sometimes be normal and results often need repeat testing and clinical interpretation.
Can my C1-INH level be normal if its function is low?
Yes. The antigen test measures how much C1 inhibitor is present, while the function test measures whether it works; autoantibodies can neutralize the protein even when the amount is normal. A low function result should be interpreted with the other complement tests and your clinical history.
What can cause acquired C1 inhibitor deficiency?
The body may use up C1 inhibitor during ongoing immune activation associated with a B-cell lymphoproliferative disorder or MGUS, an abnormal protein condition in the blood. In another mechanism, autoantibodies attach to C1 inhibitor and prevent it from working.
What does a positive anti-C1-INH antibody test mean?
A positive result supports the possibility that your immune system is attaching antibodies to C1 inhibitor and neutralizing it. A negative result does not rule out acquired angioedema, so clinicians consider it alongside C4, C1q, C1-INH level, C1-INH function, and your symptoms.
Why might my doctor screen for blood disorders after a low C1q result?
A low C1q level can occur when an underlying immune or blood disorder is activating the complement system and consuming C1 inhibitor. Doctors may therefore evaluate for conditions such as B-cell or plasma-cell disorders and MGUS, especially when swelling begins later in life without a family history.
Why might my complement and C1 inhibitor tests need to be repeated?
One abnormal result does not establish the diagnosis because complement and C1 inhibitor values must be interpreted together. Your clinician may repeat C4, C1q, C1-INH antigen, and C1-INH function tests to confirm the pattern and monitor changes over time.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Acquired angioedema with C1Inh deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you walk me through my specific C1q, C4, and C1-INH function levels?
  2. 2.Since my C1-INH function is low, but my C1-INH level (antigen) is normal, what does that tell us about how my body is disabling the protein?
  3. 3.Do my results show the presence of anti-C1-INH autoantibodies? If so, how does that change our treatment strategy?
  4. 4.Given my low C1q, what specific tests are we doing to screen for underlying conditions like B-cell disorders or MGUS?
  5. 5.How often should we repeat these blood tests to monitor if my underlying condition is being managed?

References

References (15)
  1. 1

    Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.

    Zeerleder S, Levi M

    Annals of medicine 2016; (48(4)):256-67 doi:10.3109/07853890.2016.1162909.

    PMID: 27018196
  2. 2

    Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency.

    Miyata T, Horiuchi T

    Allergology international : official journal of the Japanese Society of Allergology 2023; (72(3)):375-384 doi:10.1016/j.alit.2023.04.004.

    PMID: 37169642
  3. 3

    Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.

    Kajdácsi E, Jandrasics Z, Veszeli N, et al.

    Frontiers in immunology 2020; (11()):794 doi:10.3389/fimmu.2020.00794.

    PMID: 32431708
  4. 4

    Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.

    Banerji A, Busse P, Shennak M, et al.

    The New England journal of medicine 2017; (376(8)):717-728 doi:10.1056/NEJMoa1605767.

    PMID: 28225674
  5. 5

    The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.

    Wu MA, Castelli R

    Clinical chemistry and laboratory medicine 2016; (54(2)):207-14.

    PMID: 26068904
  6. 6

    Icatibant as acute treatment for hereditary angioedema in adults.

    Farkas H

    Expert review of clinical pharmacology 2016; (9(6)):779-88 doi:10.1080/17512433.2016.1182425.

    PMID: 27123689
  7. 7

    Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.

    Wonnaparhown A, Stefanovic A, Lugar P, Hostetler HP

    Clinical and experimental immunology 2021; (206(3)):378-383 doi:10.1111/cei.13667.

    PMID: 34586637
  8. 8

    A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.

    Gobert D, Paule R, Ponard D, et al.

    Medicine 2016; (95(33)):e4363 doi:10.1097/MD.0000000000004363.

    PMID: 27537564
  9. 9

    Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort.

    Lahuna C, Defendi F, Bouillet L, et al.

    The journal of allergy and clinical immunology. In practice 2024; (12(12)):3283-3291 doi:10.1016/j.jaip.2024.09.016.

    PMID: 39357560
  10. 10

    Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.

    Shi Y, Wang C

    Clinical immunology (Orlando, Fla.) 2021; (230()):108819 doi:10.1016/j.clim.2021.108819.

    PMID: 34358691
  11. 11

    Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.

    Zanichelli A, Azin GM, Wu MA, et al.

    The journal of allergy and clinical immunology. In practice 2017; (5(5)):1307-1313 doi:10.1016/j.jaip.2016.12.032.

    PMID: 28284781
  12. 12

    A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy.

    Zanichelli A, Arcoleo F, Barca MP, et al.

    Orphanet journal of rare diseases 2015; (10()):11 doi:10.1186/s13023-015-0233-x.

    PMID: 25758562
  13. 13

    Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients.

    Stammler R, Defendi F, Aubineau M, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(3)):542-550.e2 doi:10.1016/j.jaip.2024.12.027.

    PMID: 39756514
  14. 14

    "Nuts and Bolts" of Laboratory Evaluation of Angioedema.

    Farkas H, Veszeli N, Kajdácsi E, et al.

    Clinical reviews in allergy & immunology 2016; (51(2)):140-51 doi:10.1007/s12016-016-8539-6.

    PMID: 27142368
  15. 15

    Deletions in SERPING1 Lead to Lower C1 Inhibitor Function: Lower C1 Inhibitor Function Can Predict Disease Severity.

    Mete Gökmen N, Gülbahar O, Onay H, et al.

    International archives of allergy and immunology 2019; (178(1)):50-59 doi:10.1159/000492583.

    PMID: 30278448

This page explains the biology and laboratory patterns of acquired angioedema with C1 inhibitor deficiency for informational purposes only and does not constitute medical advice. Your allergist, immunologist, or hematologist should interpret your results and guide your care.